Cart
sales@molnova.com
IM176OUT05
CAS No. 1544871-16-0
IM176OUT05 ( IM176 OUT05; IM176OUT05, IM )
Catalog No. M27989 CAS No. 1544871-16-0
IM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 896 | Get Quote |
|
| 100MG | 1413 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIM176OUT05
-
NoteResearch use only, not for human use.
-
Brief DescriptionIM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
-
DescriptionIM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
-
SynonymsIM176 OUT05; IM176OUT05, IM
-
PathwayOthers
-
TargetOther Targets
-
RecptorTLR7;TLR8;Reactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1544871-16-0
-
Formula Weight255.8
-
Molecular FormulaC11H18ClN5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cc1ccccc1CCNC(=N)NC(N)=N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Karama Makni-Maalej, et al. The TLR7/8 agonist CL097 primes N-formyl-methionyl-leucyl-phenylalanine-stimulated NADPH oxidase activation in human neutrophils: critical role of p47phox phosphorylation and the proline isomerase Pin1. J Immunol. 2012 Nov 1;189(9):4657-65.
molnova catalog
related products
-
Eculizumab
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.
-
WJ460
WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.
-
Rituximab
Rituximab anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM.
